Dr. Steven Libutti, MD

• Surgical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• National Institute Of Health

  Fellowship Hospital

• National Cancer Institute

  Fellowship Hospital, 1996

• New York-presbyterian Hospital

  Residency Hospital, 1994

• Columbia University Vagelos College Of Physicians And Surgeons

  Medical School, 1990

• Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center, 2009-05-12

• Functional Characterization of Filamin A Interacting Protein 1-Like, a Novel Candidate for Antivascular Cancer Therapy, 2008-09-15

• Development of a novel, pan-variant aerosol intervention for COVID-19, 2021-09-20

• Tumor Vasculature-targeted Delivery of Tumor Necrosis Factor-a, 2009-01-01

• Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFa to Cancer Vasculature, 2009-03-30

• Activation of the Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Signaling Pathways Are Associated With Shortened Survival in Patients With Malignant Peritoneal Mesothelioma, 2010-09-13

• Development of a clinical decision model for thyroid nodules, 2009-08-10

• Tumor-associated endothelial cells display GSTP1 and RARß2 promoter methylation in human prostate cancer, 2006-03-02

• Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival, 2009-12-22

• Imaging features of radiofrequency ablation with heat deployed liposomal doxorubicin in hepatic tumors, 2015-07-31

• Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma, 2007-07-18

• Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by InactivatingVhlin Specific Pancreatic Cell Populations, 2009-04-02

• A Subset of Host B-Lymphocytes Control Melanoma Metastasis Through a MCAM/MUC18-dependent Interaction: Evidence from Mice and Humans, 2008-10-15

• SomaticVHLgene alterations in MEN2-associated medullary thyroid carcinoma, 2006-05-17

• Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma, 2011-02-08

• Treatment Factors Associated With Long-Term Survival Following Cytoreductive Surgery and Regional Chemotherapy for Patients with Malignant Peritoneal Mesothelioma, 2013-03-13

• Reoperation for parathyroid adenoma: A contemporary experience, 2012-09-06

• Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I (MEN1) Syndrome via Pdx1-directed Inactivation ofMen1, 2009-02-10

• Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy, 2009-09-24

• Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer, 2022-07-11